Premium Nahrungsergänzungsmittel | artgerecht

Adenocarcinoma – Causes, Symptoms and Treatment

Adenocarcinoma is a malignant tumor arising from glandular tissue. It is one of the most common cancer types and can affect many organs throughout the body.

Regular tips about health Regular tips about health

Things worth knowing about "Adenocarcinoma"

Adenocarcinoma is a malignant tumor arising from glandular tissue. It is one of the most common cancer types and can affect many organs throughout the body.

What is Adenocarcinoma?

An adenocarcinoma is a type of cancer that originates in the cells of glandular (epithelial) tissue. Glandular tissue is found throughout the body in organs such as the lungs, colon, stomach, pancreas, breast, prostate, and uterus. Adenocarcinomas are among the most frequently diagnosed cancers worldwide.

Causes and Risk Factors

The exact causes of adenocarcinoma vary depending on the organ involved. Common risk factors include:

Genetic predisposition: Family history and inherited gene mutations (e.g., BRCA1/2 in breast cancer) can significantly increase risk.
Smoking: Particularly relevant for lung and pancreatic adenocarcinomas.
Chronic inflammation: For example, inflammatory bowel disease is a known risk factor for colorectal adenocarcinoma.
Dietary habits: A low-fiber, high-fat diet is associated with an increased risk of colorectal cancer.
Hormonal factors: Relevant in breast and endometrial cancers.
Infections: Helicobacter pylori infection increases the risk of gastric adenocarcinoma; certain HPV types are linked to cervical adenocarcinomas.
Age: The risk of developing adenocarcinoma increases with advancing age.

Common Locations

Adenocarcinomas can develop in numerous organs. The most common forms include:

Colorectal adenocarcinoma: A malignant tumor of the colon or rectum – one of the most common cancers worldwide.
Lung adenocarcinoma: The most common subtype of lung cancer, frequently occurring in non-smokers.
Gastric adenocarcinoma: Often associated with Helicobacter pylori infection or dietary factors.
Pancreatic adenocarcinoma: Known for early aggressive spread and a poor prognosis.
Breast carcinoma: Most breast cancers are invasive ductal or lobular adenocarcinomas.
Prostate carcinoma: Nearly all malignant prostate tumors are adenocarcinomas.
Endometrial carcinoma: The most common uterine cancer is an adenocarcinoma of the endometrium.

Symptoms

The symptoms of adenocarcinoma depend greatly on the organ affected. General warning signs may include:

Unexplained weight loss
Persistent fatigue and weakness
Pain in the affected body region
Changes in bowel habits (e.g., blood in stool in colorectal cancer)
Persistent cough or blood in sputum (in lung cancer)
Difficulty swallowing or stomach problems (in gastric or esophageal cancer)
Palpable lumps or hardening of tissue (e.g., in the breast)

Diagnosis

Diagnosing adenocarcinoma involves several steps:

Imaging: Ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and PET-CT are used to visualize the tumor and detect possible metastases.
Endoscopy: For example, colonoscopy for suspected colorectal cancer or gastroscopy for gastric cancer.
Biopsy: Tissue sampling followed by histological analysis is the gold standard for confirming diagnosis.
Laboratory tests: Tumor markers such as CEA (colorectal), CA 19-9 (pancreatic), or PSA (prostate) can provide diagnostic clues but do not replace histological analysis.
Molecular pathology: Genetic testing to identify driver mutations (e.g., EGFR, KRAS) is essential for treatment planning.

Treatment

Treatment of adenocarcinoma depends on the tumor type, stage, location, and the overall health of the patient. Common therapeutic approaches include:

Surgical Treatment

When feasible, surgical removal of the tumor is the primary treatment goal. In early stages, complete cure may be achievable.

Radiation Therapy

Radiotherapy is often used as an adjunct to surgery or as a standalone treatment when surgery is not possible.

Chemotherapy

Cytotoxic drugs inhibit the growth of cancer cells and are frequently used in combination with other treatments, such as neoadjuvant therapy prior to surgery to reduce tumor size.

Targeted Therapy

Molecularly targeted agents specifically interfere with signaling pathways in tumor cells. Examples include EGFR inhibitors in lung adenocarcinoma and HER2-directed therapies in certain gastric and breast cancers.

Immunotherapy

Checkpoint inhibitors (e.g., PD-1/PD-L1 antibodies) enhance the immune system's ability to fight cancer cells and are used for various types of adenocarcinoma.

Prognosis

The prognosis of adenocarcinoma depends critically on the time of diagnosis. Outcomes are significantly better in early stages without metastases. Regular cancer screening and early detection are therefore of paramount importance.

References

World Health Organization (WHO): Global Cancer Observatory – Cancer Today. International Agency for Research on Cancer (IARC), 2024. Available at: https://gco.iarc.fr
National Comprehensive Cancer Network (NCCN): NCCN Clinical Practice Guidelines in Oncology. NCCN, 2024. Available at: https://www.nccn.org
Kasper D. L. et al.: Harrison's Principles of Internal Medicine, 21st Edition. McGraw-Hill Education, 2022.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category